DEADLINE EXTENDED: Support Extending and Re-designating TPS for Yemen

In the coming weeks, this administration will decide the fate of nearly 1,200 Yemeni men, women, and children, currently under Temporary Protected Status (TPS) in the United States. This administration needs to decide whether to renew TPS for Yemen by January
4, 2020 or the designation expires on March 3, 2020—sending these Yemen citizens into harm’s way. For all those eligible and impacted by the continuing crisis in Yemen, this designation provides temporary relief and safety.

Read More

Defend the Clean Water Act, Join Resolution as Original Cosponsor

Our Nation’s waterways—like the Great Lakes, Mississippi River, Everglades, Chesapeake Bay, and others—are iconic and treasured natural resources for all aspects of American life and prosperity. They serve as the source of drinking water for tens of millions
of people. They are magnets for recreation. And they support the commercial fishing, shipping, and travel industries that leads to a robust U.S. economy and good paying jobs.

Read More

Support Extending and Re-designating TPS for Yemen

In the coming weeks, this administration will decide the fate of nearly 1,200 Yemeni men, women, and children, currently under Temporary Protected Status (TPS) in the United States. This administration needs to decide whether to renew TPS for Yemen by January
4, 2020 or the designation expires on March 3, 2020—sending these Yemen citizens into harm’s way. For all those eligible and impacted by the continuing crisis in Yemen, this designation provides temporary relief and safety.

Read More

Support Proper Implementation of the DQSA

Please join our letter to the Food and Drug Administration (FDA) regarding proper implementation of the Drug Quality and Security Act (DQSA). This bipartisan letter helps address important patient safety issues and protect FDA’s drug review processes.

Read More

Support Proper Implementation of the DQSA

Please join our letter to the Food and Drug Administration (FDA) regarding proper implementation of the Drug Quality and Security Act (DQSA). This bipartisan letter helps address important patient safety issues and protect FDA’s drug review processes.

Read More